Cardlytics Continues Revenue Tightening Amid Worsening Economics (NASDAQ: CDLX)

.Financial article writer highly recommends selling Cardlytics, Inc. as a result of dropping device business economics, income obstacles, and unfavorable financial fads. Click on for this CDLX upgrade.